Osteoarthritis
Conditions
Keywords
Knee Pain, Degenerative Arthritis, Cartilage Disease, Non-drug Therapy
Brief summary
Osteoarthritis is a degenerative joint disease and is the most common form of arthritis. This study will evaluate the effectiveness of customized shoe inserts in controlling and relieving the pain of knee osteoarthritis.
Detailed description
Osteoarthritis (OA) is a chronic disease causing deterioration of the joint cartilage and the formation of bone spurs at the margins of the joints. Knee OA causes substantial pain, suffering, and disability, as well as enormous economic burden on the patient; unfortunately, treatment provides relief but not a cure. The majority of patients with symptomatic knee OA do not attain satisfactory long-term relief, even with recent advances in pain relievers. Analgesic treatment may relieve the pain but does not improve biomechanics and may even aggravate OA. Although OA is complex and not completely understood, disease onset and progression are at least partly related to responses by bone and cartilage to biomechanical loading. Devices that promote pressure reduction from the medial knee may provide pain relief while simultaneously protecting the joint from further degeneration; one such device is a lateral wedge orthotic shoe insert. When worn during weight-bearing activity, these inserts have been shown to reduce loading of the medial compartment and may provide pain relief. This study will evaluate the effectiveness of orthotic shoe inserts in controlling and relieving knee OA. The study will also assess improvements in loading biomechanics of the knee. This is a 3-year study. Patients will be randomly assigned to one of two groups; the first group will receive lateral wedge orthotic inserts and the second group will receive standard orthotic inserts. There will be 10 study visits during the course of the study. Patients will undergo X-rays and bone mineral density testing (DEXA) and 3 blood collections during the course of the study.
Interventions
DEVICELateral wedge orthotic shoe inserts
Customized lateral wedge orthotic shoe inserts
DEVICEStandard orthotic shoe inserts
Neutral orthotic inserts
Sponsors
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Rush University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Able and willing to give informed consent and to comply with the study protocol and follow-up instructions * Symptomatic and radiographic OA of the knee * Knee pain upon walking * Predominant medial compartment OA
Exclusion criteria
* Knee flexion contracture of greater than 15 degrees or inability to walk without assistance * Predominant lateral compartment OA of either knee * Greater than 3 degree valgus or greater than 12 degree varus deformity of either knee, as defined by the mechanical axis * Clinically evident OA of the ankle or hip * Clinically significant intrinsic foot disease upon podiatric evaluation, including any foot condition that may be aggravated by wearing orthotics * Substantial obesity, defined as having body mass index (BMI) greater than 35 * Anticipation of surgery involving any joint of either lower extremity in the next 3 years * Habitual use of inappropriate shoewear that would interfere with adequate use of the orthotic inserts * Inflammatory arthropathy, such as rheumatoid arthritis, systemic lupus, or active gout * Chronic infection in any joint of the lower extremities * History of fracture of either lower extremity within 6 months of study entry * History of knee or hip arthroplasty or of surgical arthroscopy of either knee within 3 months of study entry * History of intra-articular injections (glucocorticoids or hyaluronic acid derivatives) in the index knee within 6 months of study entry * Pregnancy * Any medical condition which, in the opinion of the investigator, would render the patient unable to comply with the protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction | Years 2 and 3 |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in loading of the medial knee | Years 2 and 3 |
Countries
United States
Outcome results
None listed